echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Shanghai Kaibao Tanreqing Injection is listed as a recommended drug for severe and critical diseases of the new crown

    Shanghai Kaibao Tanreqing Injection is listed as a recommended drug for severe and critical diseases of the new crown

    • Last Update: 2022-05-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 16, 2022, Shanghai Kaibao issued an announcement stating that the company's product Tanreqing injection was listed as recommended for severe and critical patients during the clinical treatment period (confirmed cases) in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" Medication


    The company's Tanreqing injection is mainly used for the treatment of acute and chronic bronchitis, pneumonia and upper respiratory tract infections caused by bacteria or viruses


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.